Abstract # 2203 Improving the Therapeutic Ratio of Prostate Brachytherapy: Dose Escalation in I-125 Prostate Implants

Presenter: Kao, Johnny

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

Patients with a minimum D90 of 180 Gy had outstanding local control based on PSA control and biopsy data. The absence of late failures with extended follow-up suggests durable tumor control. The toxicity profile, particularly long-term urinary and sexual function, was excellent and demonstrates that D90 doses ≥180 Gy are well tolerated.

Abstracts Main Page | Logout